• 1
    Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001; 24: 10691078.
  • 2
    Lustman PJ, Close RE. Depression in diabetic patients: The relationship between mood and glycemic control. J. Diabetes Complications 2005; 19: 113122.
  • 3
    Gelenberg A. Depression is still underrecognized and undertreated. Arch. Intern. Med. 1999; 159: 16571658.
  • 4
    Miranda J, Munoz R. Intervention for minor depression in primary care patients. Psychosom. Med. 1994; 56: 136141.
  • 5
    Whooley M, Simon G. Managing depression in medical outpatients. N. Engl. J. Med. 2000; 343: 19431950.
  • 6
    Bradley C, Lewis KS. Measurements of psychological wellbeing and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet. Med. 1990; 7: 445451.
  • 7
    Bech P, Gudex C, Johansen S. The WHO (ten) well-being index: Validation in diabetes. Psychother. Psychosom. 1996; 65: 183190.
  • 8
    Bonsignore M, Barkow K, Jessen F, Heun R. Validity of the five-item WHO well-being index (WHO-5) in an elderly population. Eur. Arch. Psychiatry Clin. Neurosci. 2001; 251 (Suppl. 2): II27II31.
  • 9
    Henkel V, Mergl R, Kohnen R, Maier W, Moller HJ, Hegerl U. Identifying depression in primary care: A comparison of different methods in a prospective cohort study. BMJ 2003; 326: 200201.
  • 10
    Henkel V, Mergl R, Kohnen R, Allgaier A-K, Moller H-J, Hegerl U. Use of brief depression screening tools in primary care: Consideration of heterogeneity in performance in different patient groups. Gen. Hosp. Psychiatry 2004; 26: 190198.
  • 11
    Lowe B, Spitzer RL, Graphe K et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnosis. J. Affect. Disord. 2004; 78: 131140.
  • 12
    Heun R, Burkart M, Maier M, Bech P. Internal and external validity of the WHO Well-Being Scale in the elderly general population. Acta Psychiatr. Scand. 1999; 99: 171178.
  • 13
    Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: A comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int. J. Methods Psychiatr. Res. 2003; 12: 8591.
  • 14
    Bracken B, Barona A. State of art procedures for translating, validating and using psychoeducational tests in cross-cultural assessment. School Psychol. Int. 1991; 12: 119132.
  • 15
    Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 11831197.
  • 16
    Zung W. A self-reported depression scale. Arch. Gen. Psychiatry 1969; 126: 116121.
  • 17
    Spielberger CD, Goursch RL, Lushene RE. STAI Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, California, 1970.
  • 18
    Folstein MF, Folstein SE, McHugh PR. ‘Mini-Mental State’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12: 189198.
  • 19
    McHorney CA, Ware JE Jr, Rachel Lu JF, Sherbourne CD. The MOS 36-item Short-Form Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 1994; 32: 4066.
  • 20
    Fukuda K, Kobayashi S. A study on a self-rating depression scale. Psychiatr. Neurol. Jpn 1978; 75: 673679.
  • 21
    Kitamura T, Shima S, Sugawara M, Toda MA. Temporal validation of validity of self-rating questionnaires: Repeated use of the General Health Questionnaire and Zung’s Self-Rating Depression Scale among women during antenatal and postnatal periods. Acta Psychiatr. Scand. 1994; 90: 446450.
  • 22
    Nakazato K, Mizuguchi K. Studies on psychometric characteristics of depression in the field of internal medicine. Shinshin-Igaku 1982; 22: 107112 (in Japanese).
  • 23
    Mori E, Mitani Y, Yamadori A. Usefulness of a Japanese version of the Mini-Mental State test in neurological patients. Jpn J. Neuropsychol. 1985; 1: 8289 (in Japanese).
  • 24
    Fukuhara S, Bito S, Green J, Hsiao A, Kiyoshi K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J. Clin. Epidemiol. 1998; 51: 10371044.
  • 25
    Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J. Clin. Epidemiol. 1998; 51: 10451053.
  • 26
    First MB, Spitzer RL, Gibbon MSW, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. Biometric Research Department, New York, 1997.
  • 27
    Takahashi S. The Manual for Psychiatric Diagnostic Interview. Structured Clinical Interview For DSM-IV Axis I Disorders. Nihon Hyoron-sha, Tokyo, 2002 (in Japanese).
  • 28
    Mokken RJ. A Theory and Procedure of Scale Analysis. Mouton, Paris, 1971.
  • 29
    Bech P, Moses R, Gomis R. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy-naïve Type 2 diabetes: A placebo-controlled, multicentre study. Qual. Life Res. 2003; 12: 413425.
  • 30
    Licht RW, Qvitzau S, Allerup P, Bech P. Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity? Acta Psychiatr. Scand. 2005; 111: 144149.
  • 31
    De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: A meta-analysis. Psychosom. Med. 2001; 63: 619630.
  • 32
    World Health Organization. World Health Organization Info Package: Mastering Depression in Primary Care. WHO, Regional Office of Europe, Psychiatric Research Unit, Frederiksborg, 1998.